Tyruko 300 mg concentrate for solution for infusion: Patient Alert Card
A patient alert card intended to educate patients and carers on the risk of PML whilst on natalizumab treatment and for up to 6 months afterwards, on the nature of PML and to ensure they exercise vigilance regarding its development.